Skip to content
★ Sign in to follow
SL

Shao-Lee Lin

ACELYRIN, Inc.Cue Biopharma, Inc.Horizon Therapeutics Public Ltd Co
Insider activity · 24 months0 buys7 salesCumulative net flow
Total declarations
42
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€1.9M

Latest filing published 14 Oct 2026 for Cue Biopharma, Inc., €27k.

Filing timeline

BuySale
Shao-Lee Lin

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Shao-Lee Lin: trading record in brief

Shao-Lee Lin has filed trades across 3 companies (mainly through SEC (Form 4)), most often in ACELYRIN, Inc., Horizon Therapeutics Public Ltd Co and Cue Biopharma, Inc. Between 4 January 2019 and 12 October 2026, the trades on record add up to 42 filings.

Sales make up the whole of the open-market record (10 sales, €1.9M). The rest of the record consists of 12 share grants and 5 option exercises. 2026 to date brings no purchases and 7 sales.

The latest filing, published on 14 October 2026, reports an open-market sale of €27k in Cue Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Shao-Lee Lin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations42 total
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    30,490 USD44SEC
    1,087 shares@ US$28.050.021% mcap1.6% of flowCommon StockSEC:0001725092-26-000019:1
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    275,000 USD50SEC
    10,000 shares@ US$27.500.19% mcap14.7% of flowCommon StockSEC:0001725092-26-000019:0
  • ◇
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    0SEC
    109,179 shares0Common StockSEC:0001725092-26-000013:0
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    923,733 USD42SEC
    34,225 shares@ US$26.990.64% mcap48.1% of flowCommon StockSEC:0001725092-26-000013:1
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    160,256 USD34SEC
    5,775 shares@ US$27.750.11% mcap8.3% of flowCommon StockSEC:0001725092-26-000013:2
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    147,451 USD34SEC
    5,423 shares@ US$27.190.10% mcap7.7% of flowCommon StockSEC:0001725092-26-000013:3
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    66,761 USD31SEC
    2,375 shares@ US$28.110.046% mcap3.5% of flowCommon StockSEC:0001725092-26-000013:4
  • ▼
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    308,361 USD36SEC
    10,460 shares@ US$29.480.21% mcap16.1% of flowCommon StockSEC:0001725092-26-000013:5
  • ◆
    Chief Executive OfficerExecutivesCue Biopharma, Inc.
    0SEC
    327,537 shares0Common StockSEC:0001725092-26-000006:0
  • ▼
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    66,025 USD25SEC
    9,961 shares@ US$6.628325.2% of flowCommon StockSEC:0001962918-24-000036:0
  • ▼
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    119,403 USD27SEC
    15,701 shares@ US$7.604845.4% of flowCommon StockSEC:0001962918-24-000015:0
  • ▼
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    79,188 USD25SEC
    10,691 shares@ US$7.40729.4% of flowCommon StockSEC:0001962918-24-000002:0
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    132,236 shares0Common StockSEC:0001962918-23-000036:1
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    1,161,747 shares0Common StockSEC:0001962918-23-000036:0
  • ◆
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    842,400 shares0Common StockSEC:0001962918-23-000021:0
  • ◆
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    8M USD30SEC
    337,179 shares@ US$24.6996.9% of flowCommon StockSEC:0001209191-23-028862:3
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    1,107,213 shares0Class A Common StockSEC:0001209191-23-028862:1
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    1,107,213 shares0Common StockSEC:0001209191-23-028862:2
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    677,813 shares0Class A Common StockSEC:0001209191-23-028862:4
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    677,813 shares0Common StockSEC:0001209191-23-028862:5
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    354,969 shares0Class A Common StockSEC:0001209191-23-028862:6
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    354,969 shares0Common StockSEC:0001209191-23-028862:7
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    354,969 shares0Class A Common StockSEC:0001209191-23-028862:8
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    354,969 shares0Common StockSEC:0001209191-23-028862:9
  • ●
    Chief Executive OfficerExecutivesACELYRIN, Inc.
    0SEC
    349,898 shares0Class A Common StockSEC:0001209191-23-028862:10

25 of 42 declarations